GHK-Cu for acne scars: what the evidence actually supports

What's this video probably claiming?

Based on the caption and hashtag context, @adwellnesscoaching is almost certainly crediting GHK-Cu (copper peptide GHK-Cu, or glycyl-L-histidyl-L-lysine copper) with visible improvements in acne scars and skin texture. The creator acknowledges other factors are involved, which is refreshingly honest by wellness-TikTok standards. Still, this type of content typically implies that topical or injectable GHK-Cu was a meaningful driver of before-and-after results, often shown through closeup skin comparisons. The hashtags acnescars and skintexture suggest the video is positioning GHK-Cu as a remodeling agent, not just a generic anti-aging peptide. Given the peptide therapy category tag, there's also a real chance this blurs the line between topical cosmetic formulations and compounded injectable peptide therapy, two very different regulatory and evidence categories.

What does the science actually show?

GHK-Cu has a legitimate mechanistic story. It binds copper ions and has been shown in vitro to stimulate collagen, elastin, and glycosaminoglycan synthesis. Pickart and Margolina (2018, Cosmetics) summarized decades of research showing GHK-Cu upregulates genes involved in tissue remodeling and downregulates genes linked to inflammation. That's real. The problem is that most of this work is cell culture or animal data. Human clinical trials are sparse and small. One of the more cited human studies, Leyden et al. (2005, Journal of Cosmetic Dermatology), found that a topical GHK-Cu formulation applied twice daily for 12 weeks produced measurable improvements in fine lines and skin laxity compared to placebo, but the effect sizes were modest. Acne scar remodeling specifically, which involves deeper dermal disruption than fine lines, has essentially no dedicated randomized controlled trial data. The gap between the mechanistic promise and the clinical proof is wide.

Where does the social media noise diverge from clinical reality?

TikTok GHK-Cu content almost universally skips the dosing and delivery problem. Topical copper peptides face a significant penetration barrier. The stratum corneum doesn't easily let peptides reach the dermal layer where collagen remodeling actually happens. Formulation matters enormously, concentration, vehicle, pH, and stabilization, but creators rarely specify what product they're using or at what concentration. Injectable GHK-Cu, on the other hand, sidesteps the penetration issue but introduces a completely different regulatory question. Compounded injectable peptides are not FDA-approved for cosmetic indications, and the FDA has repeatedly flagged compounded peptides for quality and safety concerns. Conflating a drugstore copper peptide serum with a compounded injectable is a meaningful misrepresentation. Content like this also rarely acknowledges that acne scar improvement timelines measured in months overlap with natural skin cycling, making attribution to any single ingredient genuinely difficult.

What should you actually know?

GHK-Cu is not a scam. The mechanistic research is real and interesting, and it's one of the more studied cosmetic peptides. But calling it a significant credit for acne scar improvement without specifying the product type, concentration, delivery method, and what else was happening in the routine is not a health claim, it's a testimonial. Those are very different things. If you're interested in peptide-based skin remodeling, the stronger clinical evidence base sits with retinoids and certain growth factors. GHK-Cu may have additive value in a well-formulated topical, but the evidence doesn't yet support positioning it as a primary driver of scar revision. Anyone seeing injectable GHK-Cu marketed for cosmetic skin outcomes should ask hard questions about what oversight exists for that compounded product. Anecdote plus mechanism does not equal proof. That's true whether the person sharing the anecdote has 300 followers or 300,000.